Managing antipsychotic intolerance via genetics.

The standard pharmacological approach in psychiatric treatment, based on trial and error within a class of drug, often necessitates medication changes due to lack of efficacy or occurrence of adverse effects. The following case described how a more personalized pharmacogenetic approach could facilitate selection of effective treatment (Hudnik et al., 2024). [ABSTRACT FROM AUTHOR]